These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3513061)

  • 21. Aztreonam in the treatment of soft tissue infections including diabetic foot infections.
    Torres A; Ramírez-Ronda CH
    Bol Asoc Med P R; 1985 May; 77(5):191-4. PubMed ID: 3860207
    [No Abstract]   [Full Text] [Related]  

  • 22. Aztreonam in gram-negative infections in children.
    Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
    Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
    [No Abstract]   [Full Text] [Related]  

  • 23. Gram-negative aerobic bacterial infections: a focus on directed therapy, with special reference to aztreonam.
    Rev Infect Dis; 1985; 7 Suppl 4():S537-843. PubMed ID: 4081472
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the therapeutic efficacy of aztreonam in the treatment of infection caused by sensitive microorganisms].
    Tirone F; Musca G; Filomia D; Vigna L
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):85-8. PubMed ID: 2798996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery-related infections: a challenge for the physician. Introduction.
    Nichols RL
    Surg Gynecol Obstet; 1990; 171 Suppl():9-10. PubMed ID: 2244296
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro and in vivo experience with carumonam: a preliminary report.
    Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H
    J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334
    [No Abstract]   [Full Text] [Related]  

  • 27. Aztreonam's role in the treatment of gram-negative infections. Proceedings of a symposium. March 15, 1989, New York, New York.
    Am J Med; 1990 Mar; 88(3C):1S-43S. PubMed ID: 2316553
    [No Abstract]   [Full Text] [Related]  

  • 28. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical review and antibacterial effect of aztreonam in infections in obstetrics and gynecology].
    Fujimoto S; Makinoda S; Tanaka T; Ichinohe K
    Jpn J Antibiot; 1985 Dec; 38(12):3513-9. PubMed ID: 3841730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial peritonitis. Protecting the high-risk patient.
    Jones LM; Miller S
    Am Surg; 1984 Jul; 50(7):358-61. PubMed ID: 6378000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with aztreonam in Germany and Austria.
    Stille W; Gillissen J
    Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety profile of aztreonam in clinical trials.
    Newman TJ; Dreslinski GR; Tadros SS
    Rev Infect Dis; 1985; 7 Suppl 4():S648-55. PubMed ID: 2934785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of aztreonam in serious gram-negative infections.
    Smith G; Bunney RG; Farrell ID; Wood MJ
    J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
    McKellar PP
    Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefamandole in the treatment of serious bone and joint diseases.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
    Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical studies of aztreonam in Japan.
    Hara K; Kobayashi H; Nishiura T; Yura J; Saito A
    Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symposium on antimicrobial therapy. V. The carbapenems and monobactams.
    Greenfield RA
    J Okla State Med Assoc; 1993 Feb; 86(2):63-5. PubMed ID: 8331460
    [No Abstract]   [Full Text] [Related]  

  • 39. Colorectal surgery: short-term prophylaxis with aztreonam plus clindamycin versus gentamicin plus clindamycin.
    Puleo S; Sammartino R; Blandino G; Tempera G; Scilletta B; Rodolico G
    J Chemother; 1989 Jul; 1(4 Suppl):1008-9. PubMed ID: 16312746
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.